AUSTRALIAN Securities Exchange-listed biotech business, Holista Colltech Ltd, is more than doubling its shipments to Australia and New Zealand of NatShield sanitisers in response to rising demand from pharmacies in response to concerns over the coronavirus.
In a statement the company said it received orders for 30,000 units of the sanitiser from pharmacy groups headquartered in Sydney and Melbourne, last week for the Australian and New Zealand markets.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Feb 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Feb 20
